Mirae Asset Global Investments Co., Ltd.
Position in ETON — Eton Pharmaceuticals, Inc.
CIK 1569395
SEOUL, M5
Position in ETON
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$44,345
+$9,818 QoQ
Shares Held
1,225
-12.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#126
of 164 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $20,006,890 across 33 Drug Manufacturers - Specialty & Generic names. ETON ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
108,368 | $7,787,323 | |
| 2 | VTRS |
Viatris Inc
|
305,332 | $4,848,671 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,119 | $2,231,797 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,700 | $1,634,837 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
23,364 | $574,988 | |
| 6 | ALKS |
Alkermes plc.
|
7,454 | $390,552 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,982 | $382,548 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,947 | $303,124 |
All Filings in ETON
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,345 | 1,225 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $34,527 | 1,399 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $22,033 | 1,303 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||